Long-term efficacy and safety of betibeglogene autotemcel for β-thalassemia
Dr. Alexis Thompson discusses the long-term efficacy and safety of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia. The study documented sustained transfusion independence for up to 10 years with a safety profile consistent with myeloablative…